ASCRS Subspecialty Day preview
ASCRS Subspecialty Day will take place on Friday, April 10, ahead of the 2026 ASCRS Annual Meeting, and promises exciting content across the fields of cornea, glaucoma, and refractive surgery.
Browse articles from EyeWorld.org from the refractive archives. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
ASCRS Subspecialty Day will take place on Friday, April 10, ahead of the 2026 ASCRS Annual Meeting, and promises exciting content across the fields of cornea, glaucoma, and refractive surgery.
While not a common approach or its primary indication, the ICL (STAAR Surgical) can be used as a supplementary/piggyback IOL in some patients. Three physicians discussed how this off-label approach to using the ICL is opening doors to treat certain patients.
Karolinne Rocha, MD, PhD, shared what readers can expect in the Refractive section of this issue and provided some of her own thoughts on the topics.
Nailing outcomes with presbyopia-correcting IOLs is important for many reasons—one of them being patient expectations, as they are paying out of pocket for an advanced-technology lens. But even when you’ve had an excellent surgery, postop complaints can trickle in, and the possible causes for the dissatisfaction are diverse.
Dysfunctional lens syndrome has evolved from a theoretical framework to a clinically validated tool that’s reshaping patient education and surgical decision making. The dysfunctional lens staging system now plays a role in identifying the right intervention at the right time, particularly in the growing field of custom lens replacement.
When it comes to refractive procedures, there are many options available. Several physicians discussed what they’re using and the options available, notably market penetration of the Implantable Collamer Lens (ICL, STAAR Surgical) and SMILE in different areas and how this has changed over the years.
Since its approval, the Light Adjustable Lens (LAL, RxSight) has become well known for the successful outcomes that it can provide for patients. Four ophthalmologists shared their experience with the product and what they’ve learned about limitations, how to work through challenges, and more.
“As healthcare practitioners, we’re constantly looking to provide the highest quality of care. We research to learn more about materials, investigate new technologies, and query for data on efficacy measures,” said Karolinne Rocha, MD, PhD, before introducing the articles in this issue’s Refractive section.
Three surgeons weighed in on the pros and cons of different lens materials as well as what may be coming in the future.
The second Business of Refractive Cataract Surgery (BRiCS) Summit will take place October 3–5 in Chicago, Illinois, giving a new set of surgeon-implementor teams the opportunity to gain insights and resources to enhance their advanced-technology IOL practice.